XML 44 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Stock Award Plans (Tables)
12 Months Ended
Dec. 31, 2020
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]  
Compensation Cost Breakdown in Statement of Earnings

The Company has share-based compensation plans which are described below. The compensation cost that has been charged against earnings for the Company’s stock award plans and the income tax benefit recognized in the statement of earnings for stock awards were as follows (in thousands):

 
Year Ended December 31,
 
   
2020
   
2019
   
2018
 
Compensation cost
 
$
14,722
   
$
13,612
   
$
19,104
 
Income tax benefit
 
$
4,143
   
$
3,368
   
$
5,903
 
Stock Option Valuation Assumptions

The key input variables used in valuing the stock options granted were as follows:

   
Year Ended December 31,
 
 
2020
   
2019
   
2018
 
Dividend yield
 
None
   
None
   
None
 
Average risk-free interest rate
   
1.3
%
   
2.5
%
   
2.7
%
Stock price volatility
   
28
%
   
28
%
   
27
%
Estimated option term
 
5.3 years
   
5.3 years
   
5.5 years
 
Employee Plan [Member]  
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]  
Stock Option Activity

The following is a summary of the stock option activity under the employee plan described above:

 
Outstanding
Non-
Qualified or
Nonincentive
Stock
Awards
   
Weighted
Average
Exercise
Price
 
Outstanding at December 31, 2019
   
486,059
   
$
71.65
 
Granted
   
114,600
   
$
73.29
 
Exercised
   
(19,851
)
 
$
64.42
 
Canceled or expired
   
(3,291
)
 
$
95.18
 
Outstanding at December 31, 2020
   
577,517
   
$
72.09
 
Outstanding and Exercisable Stock Options

The following table summarizes information about the Company’s outstanding and exercisable stock options under the employee plan at December 31, 2020:

   
Options Outstanding
   
Options Exercisable
 
Range of Exercise
Prices
   
Number
Outstanding
   
Weighted
Average
Remaining
Contractual
Life in
Years
   
Weighted
Average
Exercise
Price
   
Aggregated
Intrinsic
Value
   
Number
Exercisable
   
Weighted
Average
Exercise
Price
   
Aggregated
Intrinsic
Value
 
$
51.23
     
62,315
     
2.1
   
$
51.23
     
-
     
62,315
   
$
51.23
     
-
 
$
64.65 – $68.50
     
94,218
     
3.5
   
$
67.26
             
63,218
   
$
68.43
         
$
73.29 – $75.50
     
380,289
     
4.6
   
$
74.32
             
157,176
   
$
74.98
         
$
84.90 – $101.46
     
40,695
     
1.0
   
$
94.31
             
36,225
   
$
95.47
         
$
51.23 – $101.46
     
577,517
     
3.9
   
$
72.09
   
$
37,000
     
318,934
   
$
71.37
   
$
37,000
 
Restricted Stock Award Activity

The following is a summary of the restricted stock award activity under the employee plan described above:

 
Unvested
Restricted
Stock Award
Shares
   
Weighted
Average
Grant Date
Fair Value
Per Share
 
Nonvested balance at December 31, 2019
   
134,669
   
$
63.28
 
Vested
   
(48,450
)
 
$
63.24
 
Forfeited
   
(2,317
)
 
$
62.46
 
Nonvested balance at December 31, 2020
   
83,902
   
$
63.33
 
RSU Activity

The following is a summary of RSU activity under the employee plan described above:

 
Unvested RSUs
   
Weighted
Average Grant
Date Fair Value
Per Unit
 
Nonvested balance at December 31, 2019
   
255,167
   
$
74.96
 
Granted
   
153,460
   
$
73.04
 
Vested
   
(64,039
)
 
$
75.08
 
Forfeited
   
(6,170
)
 
$
73.91
 
Nonvested balance at December 31, 2020
   
338,418
   
$
74.09
 
Director Plan [Member]  
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]  
Stock Option Activity

The following is a summary of the stock option activity under the director plan described above:

 
Outstanding
Non-
Qualified or
Nonincentive
Stock
Awards
   
Weighted
Average
Exercise
Price
 
Outstanding at December 31, 2019
   
115,756
   
$
73.68
 
Exercised
   
(12,000
)
 
$
41.24
 
Outstanding at December 31, 2020
   
103,756
   
$
77.44
 
Outstanding and Exercisable Stock Options

The following table summarizes information about the Company’s outstanding and exercisable stock options under the director plan at December 31, 2020:

   
Options Outstanding
   
Options Exercisable
 
Range of Exercise
Prices
   
Number
Outstanding
   
Weighted
Average
Remaining
Contractual
Life in
Years
   
Weighted
Average
Exercise
Price
   
Aggregate
Intrinsic
Value
   
Number
Exercisable
   
Weighted
Average
Exercise
Price
   
Aggregate
Intrinsic
Value
 
$
56.45
     
13,276
     
0.3
   
$
56.45
     
-
     
13,276
   
$
56.45
     
-
 
$
61.89 – $62.48
     
22,000
     
1.6
   
$
62.21
             
22,000
   
$
62.21
         
$
70.65 – $99.52
     
68,480
     
3.4
   
$
86.39
             
68,480
   
$
86.39
         
$
56.45 – $99.52
     
103,756
     
2.6
   
$
77.44
   
$
     
103,756
   
$
77.44
   
$
 
Restricted Stock Award Activity

The following is a summary of the restricted stock award activity under the director plan described above:

 
Unvested
Restricted
Stock Award
Shares
   
Weighted
Average
Grant Date
Fair Value
Per Share
 
Nonvested balance at December 31, 2019
   
1,739
   
$
83.68
 
Granted
   
39,913
   
$
49.84
 
Vested
   
(40,748
)
 
$
51.28
 
Nonvested balance at December 31, 2020
   
904
   
$
49.84